Literature DB >> 34076463

Hemodynamic Assessment of Structural Heart Disease Using 4D Flow MRI: How We Do It.

Kathleen Jacobs1, Lewis Hahn1, Michael Horowitz1, Seth Kligerman1, Shreyas Vasanawala2, Albert Hsiao1.   

Abstract

MRI is an essential diagnostic tool in the anatomic and functional evaluation of cardiovascular disease. In many practices, 2D phase-contrast (2D-PC) MRI has been used for blood flow quantification. Four-dimensional flow MRI is a time-resolved volumetric acquisition that captures the vector field of blood flow along with anatomic images. It also provides a simpler acquisition compared with 2D-PC and facilitates a more accurate and comprehensive hemodynamic assessment. Advancements in accelerated imaging have significantly shortened scanning times for 4D flow MRI while preserving image quality, enabling this technology to transition from the research arena to routine clinical practice. In this article, we review technical optimization based on our more than 10 years of clinical experience with 4D flow MRI. We also present pearls and pitfalls in the practical application of 4D flow MRI, including how to quantify cardiovascular shunts, valvular or vascular stenosis, and valvular regurgitation. As experience increases, and as 4D flow sequences and postprocessing software become more broadly available, 4D flow MRI will likely become an essential component of cardiac imaging in practices involved in the management of congenital and acquired structural heart disease.

Entities:  

Keywords:  4D flow MRI; cardiac MRI; congenital heart disease; structural heart disease

Mesh:

Year:  2021        PMID: 34076463     DOI: 10.2214/AJR.21.25978

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  1 in total

Review 1.  Rationale and clinical applications of 4D flow cardiovascular magnetic resonance in assessment of valvular heart disease: a comprehensive review.

Authors:  Miroslawa Gorecka; Malenka M Bissell; David M Higgins; Pankaj Garg; Sven Plein; John P Greenwood
Journal:  J Cardiovasc Magn Reson       Date:  2022-08-22       Impact factor: 6.903

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.